Related Experiment Video
Updated: Jul 10, 2026

06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.4K
Myxedema Coma-associated Pancytopenia: A Case Report
David A Stein1, Orit Twito1,2, Yoav Geva1,3
1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rambam Maimonides Medical Journal
|November 6, 2024
Summary
Myxedema coma, a severe form of hypothyroidism, can cause pancytopenia (low blood cell counts). Prompt treatment of hypothyroidism led to the recovery of blood counts in this rare case.
Area of Science:
- Endocrinology
- Hematology
Background:
- Pancytopenia presents a diagnostic challenge due to diverse etiologies.
- Myxedema coma is a critical manifestation of severe, untreated hypothyroidism.
Observation:
- A 53-year-old male with untreated hypothyroidism presented with altered mental status and pancytopenia.
- The patient exhibited vital instability upon admission.
Findings:
- The patient was diagnosed with myxedema coma-associated pancytopenia.
- Treatment with levothyroxine, hydrocortisone, and supportive care resulted in gradual clinical improvement and normalized blood counts.
Implications:
- This case highlights myxedema coma as a crucial differential diagnosis for pancytopenia, particularly in elderly patients with limited healthcare access.
- Recognizing this association can improve diagnostic timeliness and patient outcomes, preventing complications of untreated hypothyroidism.
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

